PMC:7335494 / 28720-28970
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T220 | 224-227 | Body_part | denotes | LPS | http://purl.org/sig/ont/fma/fma82785 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T286 | 37-39 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T332 | 131-137 | Chemical | denotes | inulin | http://purl.obolibrary.org/obo/CHEBI_15443 |
T333 | 141-153 | Chemical | denotes | maltodextrin | http://purl.obolibrary.org/obo/CHEBI_25140 |
T334 | 199-205 | Chemical | denotes | Inulin | http://purl.obolibrary.org/obo/CHEBI_15443 |
T335 | 224-227 | Chemical | denotes | LPS | http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T134 | 0-250 | Sentence | denotes | Randomized controlled clinical trial 52 overweight/obese women with T2DM Patients received either 10 g/d of oligofructose-enriched inulin or maltodextrin (control) for 8 weeks oligofructose-enriched-Inulin: ↓ CRP, TNF-α and LPS Dehghan et al. (2014b) |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T62 | 40-50 | Phenotype | denotes | overweight | http://purl.obolibrary.org/obo/HP_0025502 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2062 | 164-189 | CHEBI:47916;CHEBI:47916 | denotes | for 8 weeks oligofructose |